Document Detail

Increased serum anandamide level at ruptured plaque site in patients with acute myocardial infarction.
MedLine Citation:
PMID:  19527302     Owner:  NLM     Status:  MEDLINE    
Inflammation caused by activated macrophages and T lymphocytes may trigger plaque rapture in acute coronary syndrome (ACS). Anandamide and 2-arachidonylglycerol (2-AG) are macrophage-derived signal lipids and may be involved in the pathogenesis of ACS, but no clinical relevant data have been reported. In 43 acute myocardial infarction (AMI) patients (66 +/- 2 years), blood samples were obtained from the aortic root and the infarct-related coronary artery (IRA) using a PercuSurge system during primary percutaneous coronary intervention (PCI). In six patients with stable effort angina (SEA) (56 +/- 6 years), blood samples were obtained from the site of stenosis during elective PCI. In 25 of the 43 AMI patients, anandamide was detected in the serum. Serum anandamide level was 35 +/- 20 pmol/mL in the aorta and was significantly increased to 401 +/- 134 pmol/mL in the IRA (P < 0.01). 2-AG was undetectable in most of the patients. In patients with SEA, neither anandamide nor 2-AG was detected in the serum at the plaque site. In AMI patients with anandamide detected, left ventricular ejection fraction at 2 weeks after PCI was increased by 3.7 +/- 2.1% compared with that at the acute phase, while it was decreased by 3.0 +/- 1.8% in those without anandamide detected (P < 0.05). The serum anandamide level at the culprit lesion was elevated compared with the systemic level in a significant number of AMI patients, indicating the synthesis of anandamide at the IRA. Anandamide was suggested to be derived from ruptured plaque and may exert beneficial effects in humans.
Naotaka Maeda; Tomohiro Osanai; Motoi Kushibiki; Takayuki Fujiwara; Yujin Tamura; Shingen Oowada; Takumi Higuma; Shingo Sasaki; Jin Yokoyama; Fuminobu Yoshimachi; Toshiro Matsunaga; Hiroyuki Hanada; Ken Okumura
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Fundamental & clinical pharmacology     Volume:  23     ISSN:  1472-8206     ISO Abbreviation:  Fundam Clin Pharmacol     Publication Date:  2009 Jun 
Date Detail:
Created Date:  2009-06-16     Completed Date:  2009-08-25     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8710411     Medline TA:  Fundam Clin Pharmacol     Country:  England    
Other Details:
Languages:  eng     Pagination:  351-7     Citation Subset:  IM    
Department of Cardiology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angina Pectoris / physiopathology
Angioplasty, Transluminal, Percutaneous Coronary
Aorta / physiopathology
Arachidonic Acids / biosynthesis,  blood*
Coronary Vessels / physiopathology*
Glycerides / blood
Inflammation / etiology,  physiopathology
Middle Aged
Myocardial Infarction / physiopathology*
Polyunsaturated Alkamides / blood*
Rupture, Spontaneous
Reg. No./Substance:
0/Arachidonic Acids; 0/Glycerides; 0/Polyunsaturated Alkamides; 53847-30-6/2-arachidonylglycerol; 94421-68-8/anandamide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The chronic oral administration of arginine aspartate decreases secretion of IGF-1 and IGFBP-3 in he...
Next Document:  Parental perspectives on preterm children's oral health behaviour and experience of dental care duri...